⌘K

Login Start Free

Home/Filings/4/0001213900-17-010216

4//SEC Filing

BACHA JEFFREY 4

Accession 0001213900-17-010216

CIK 0001498382other

View on SEC.gov Company Profile

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 7:55 PM ET

Size

4.8 KB

Accession

0001213900-17-010216

Insider Transaction Report

Form 4

Period: 2017-09-29

DelMar Pharmaceuticals, Inc.DMPI

CEO and President10% Owner

Transactions

Other
Common Stock
2017-09-29$3.20/sh+176$563→ 53,697 total

Footnotes (1)

[F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.

Documents

1 file

4
f4092917bacha_delmarpharm.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

DelMar Pharmaceuticals, Inc.

CIK 0001498382

Entity typeother

Related Parties

1

filerCIK 0001432149

Filing Metadata

Form type: 4
Filed: Oct 1, 8:00 PM ET
Accepted: Oct 2, 7:55 PM ET
Size: 4.8 KB

View on SEC.gov